Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Climb Bio (CLYM) Institutional Ownership

Climb Bio logo
$9.67 -0.21 (-2.16%)
Closing price 03:59 PM Eastern
Extended Trading
$9.64 -0.02 (-0.23%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Climb Bio (NASDAQ:CLYM)

Current
Institutional Ownership
Percentage
69.76%
Number of
Institutional Buyers
(last 12 months)
38
Total
Institutional Inflows
(last 12 months)
$33.85M
Number of
Institutional Sellers
(last 12 months)
15
Total
Institutional Outflows
(last 12 months)
$96.61M
Get CLYM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Climb Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CLYM Institutional Buying and Selling by Quarter

Climb Bio Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2026Bank of America Corp DE52,921$363K0.0%+945.2%0.092%
5/18/2026ADAR1 Capital Management LLC597,662$4.09M0.2%-58.3%1.044%
5/16/2026 The Manufacturers Life Insurance Company 156,317$1.07M0.0%+11.2%0.273%
5/15/2026 OMERS ADMINISTRATION Corp16,700$114K0.0%-80.5%0.029%
5/15/2026 Affinity Asset Advisors LLC700,000$4.80M0.2%-46.2%1.222%
5/14/2026 Renaissance Technologies LLC217,300$1.49M0.0%-32.2%0.379%
5/7/2026 Dimensional Fund Advisors LP104,437$715K0.0%N/A0.219%
3/20/2026 Hsbc Holdings PLC24,744$99K0.0%+107.2%0.052%
2/26/2026 Seven Fleet Capital Management LP76,400$306K0.2%N/A0.112%
2/23/2026 Virtu Financial LLC10,655$43K0.0%N/A0.016%
2/18/2026 XTX Topco Ltd34,852$139K0.0%+19.4%0.051%
2/18/2026 Squadron Capital Management LLC100,000$400K0.2%N/A0.147%
2/18/2026 Sphera Funds Management LTD.932,247$3.73M0.7%+114.4%1.367%
2/18/2026 Millennium Management LLC296,314$1.19M0.0%-37.2%0.435%
2/18/2026 Balyasny Asset Management L.P.14,236$57K0.0%N/A0.021%
2/18/2026 Bridgeway Capital Management LLC159,300$637K0.0%+45.7%0.234%
2/18/2026 683 Capital Management LLC201,652$807K0.0%N/A0.296%
2/17/2026ADAR1 Capital Management LLC1,432,475$5.73M0.4%+972.8%2.101%
2/17/2026 MPM Bioimpact LLC2,671,480$10.69M1.2%N/A3.918%
2/17/2026 RA Capital Management L.P.11,293,828$45.18M0.5%-64.1%16.565%
2/17/2026Kotler Kevin400,000$1.60M0.4%N/A0.587%
2/17/2026 Price T Rowe Associates Inc. MD1,923,639$7.70M0.0%+265.1%2.821%
2/17/2026 Blair William & Co. IL11,000$44K0.0%N/A0.016%
2/17/2026 Persistent Asset Partners Ltd9,228$37K0.0%-67.3%0.014%
2/16/2026 OMERS ADMINISTRATION Corp85,466$342K0.0%N/A0.125%
2/16/2026 ArchPoint Investors121,400$486K0.1%N/A0.178%
2/16/2026 Barclays PLC61,853$247K0.0%+149.9%0.091%
2/13/2026 Marshall Wace LLP304,015$1.22M0.0%+32.2%0.446%
2/13/2026 The Manufacturers Life Insurance Company 140,617$567K0.0%+261.5%0.206%
2/13/2026 Hudson Bay Capital Management LP48,736$195K0.0%N/A0.071%
2/13/2026 State Street Corp128,900$516K0.0%+25.0%0.189%
2/12/2026 Jane Street Group LLC187,403$750K0.0%+135.3%0.275%
2/12/2026 Renaissance Technologies LLC320,600$1.28M0.0%-40.3%0.470%
2/10/2026 TD Asset Management Inc246,200$985K0.0%+175.4%0.361%
2/10/2026 Goldman Sachs Group Inc.224,883$900K0.0%+205.1%0.330%
1/30/2026 Citizens Financial Group Inc. RI28,168$113K0.0%-38.8%0.041%
1/28/2026 Peapod Lane Capital LLC565,992$2.26M1.9%+0.7%0.830%
1/1/2026 JPMorgan Chase & Co.22,012$44K0.0%-89.5%0.032%
11/17/2025 Susquehanna International Group LLP142,450$286K0.0%+128.4%0.209%
11/17/2025 Prelude Capital Management LLC40,718$82K0.0%N/A0.060%
The 1934 playbook (Ad)

In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it coming — but those who did walked away wealthy.Trump holds that same legal authority today. Advisors close to the administration believe he may use it.If he does, the transfer moves fast. The window to position yourself on the right side is already closing.tc pixel

11/17/2025 Millennium Management LLC471,704$948K0.0%-1.7%0.692%
11/14/2025 Deep Track Capital LP509,789$1.03M0.0%-51.0%0.748%
11/14/2025ADAR1 Capital Management LLC133,530$268K0.0%+11.9%0.196%
11/14/2025 Shay Capital LLC150,000$302K0.0%-63.9%0.220%
11/14/2025 Two Sigma Investments LP112,681$226K0.0%-37.3%0.165%
11/14/2025 Bridgeway Capital Management LLC109,300$220K0.0%-18.6%0.160%
11/13/2025 UBS Group AG405,404$815K0.0%+6.0%0.595%
11/10/2025 Peapod Lane Capital LLC561,866$1.13M1.0%+1.1%0.824%
11/10/2025 Persistent Asset Partners Ltd28,221$57K0.0%-80.6%0.041%
11/7/2025Vanguard Group Inc.1,315,811$2.65M0.0%-1.2%1.942%
11/7/2025 JPMorgan Chase & Co.22,012$44K0.0%-89.5%0.032%
10/31/2025 Vanguard Personalized Indexing Management LLC14,546$29K0.0%N/A0.021%
10/24/2025 Citizens Financial Group Inc. RI46,000$92K0.0%N/A0.068%
8/15/2025 Shay Capital LLC415,000$515K0.1%+107.5%0.612%
8/14/2025 Jane Street Group LLC148,180$184K0.0%N/A0.219%
8/14/2025 Diadema Partners LP702,135$871K0.3%+4.8%1.039%
8/14/2025 Qube Research & Technologies Ltd34,310$43K0.0%N/A0.051%
8/13/2025 Marshall Wace LLP36,738$46K0.0%N/A0.054%
8/13/2025 Stonepine Capital Management LLC116,147$144K0.1%N/A0.172%
8/12/2025 JPMorgan Chase & Co.210,122$261K0.0%-31.4%0.311%
8/8/2025 Geode Capital Management LLC311,721$387K0.0%-53.7%0.461%
8/8/2025 Nan Fung Trinity HK Ltd.463,654$575K0.1%N/A0.686%
8/1/2025 Y Intercept Hong Kong Ltd127,952$159K0.0%N/A0.189%
6/27/2025 Goldman Sachs Group Inc.120,742$147K0.0%N/A0.179%
5/16/2025Goldman Sachs Group Inc.120,742$147K0.0%N/A0.179%
5/16/2025AQR Capital Management LLC21,808$27K0.0%N/A0.032%
5/16/2025Allostery Investments LP244,988$299K0.4%N/A0.363%
5/16/2025ADAR1 Capital Management LLC119,320$146K0.0%N/A0.177%
5/15/2025RA Capital Management L.P.31,419,267$38.33M0.6%N/A46.495%
5/14/2025Affinity Asset Advisors LLC1,500,000$1.83M0.2%N/A2.220%
5/13/2025Persistent Asset Partners Ltd145,760$178K0.1%N/A0.216%
5/12/2025Nuveen LLC39,034$48K0.0%N/A0.058%
5/9/2025Charles Schwab Investment Management Inc.70,093$86K0.0%N/A0.104%
5/8/2025XTX Topco Ltd27,660$34K0.0%N/A0.041%
5/7/2025TD Asset Management Inc89,400$109K0.0%N/A0.132%
4/30/2025Peapod Lane Capital LLC553,816$676K0.8%N/A0.821%
4/29/2025Bank of New York Mellon Corp64,914$79K0.0%N/A0.096%


CLYM Institutional Ownership - Frequently Asked Questions

During the previous two years, 53 institutional investors and hedge funds held shares of Climb Bio. The most heavily invested institutionals were RA Capital Management L.P. ($45.18M), MPM Bioimpact LLC ($10.69M), Price T Rowe Associates Inc. MD ($7.70M), Affinity Asset Advisors LLC ($4.80M), ADAR1 Capital Management LLC ($4.09M), Sphera Funds Management LTD. ($3.73M), and Vanguard Group Inc. ($2.65M).Learn more on Climb Bio's institutional investors.

69.76% of Climb Bio's stock is owned by institutional investors. Learn more on CLYM's institutional investor holdings.

Of the 46 institutional investors that purchased Climb Bio's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($31.42M), MPM Bioimpact LLC ($2.67M), Affinity Asset Advisors LLC ($1.50M), ADAR1 Capital Management LLC ($1.43M), Price T Rowe Associates Inc. MD ($1.40M), Peapod Lane Capital LLC ($564.14K), and Sphera Funds Management LTD. ($497.41K).

Institutional investors have bought a total of 9,348,893 shares in the last 24 months. This purchase volume represents approximately $33.85M in transactions.

Of the 15 institutional investors that sold Climb Bio's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: RA Capital Management L.P. ($20.13M), ADAR1 Capital Management LLC ($834.81K), Affinity Asset Advisors LLC ($600K), Deep Track Capital LP ($530.33K), JPMorgan Chase & Co. ($472.52K), Geode Capital Management LLC ($362.09K), and Renaissance Technologies LLC ($319.80K).

Institutional investors have sold a total of 24,023,652 shares in the last 24 months. This volume of shares sold represents approximately $96.61M in transactions.



This page (NASDAQ:CLYM) was last updated on 5/19/2026 by MarketBeat.com Staff.
From Our Partners